BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29692669)

  • 21. Endometrial stem/progenitor cells in menstrual blood and peritoneal fluid of women with and without endometriosis.
    Masuda H; Schwab KE; Filby CE; Tan CSC; Tsaltas J; Weston GC; Gargett CE
    Reprod Biomed Online; 2021 Jul; 43(1):3-13. PubMed ID: 34011465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.
    Sagsveen M; Farmer JE; Prentice A; Breeze A
    Cochrane Database Syst Rev; 2003; 2003(4):CD001297. PubMed ID: 14583930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paracrine changes in the peritoneal environment of women with endometriosis.
    Küpker W; Schultze-Mosgau A; Diedrich K
    Hum Reprod Update; 1998; 4(5):719-23. PubMed ID: 10027625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial biomarkers for the non-invasive diagnosis of endometriosis.
    Gupta D; Hull ML; Fraser I; Miller L; Bossuyt PM; Johnson N; Nisenblat V
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD012165. PubMed ID: 27094925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis.
    Fu L; Osuga Y; Yano T; Takemura Y; Morimoto C; Hirota Y; Schally AV; Taketani Y
    Fertil Steril; 2009 Jul; 92(1):47-53. PubMed ID: 18684444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation to efficiency of the multifunction method оf endometriosis ovariеs treatment.
    Nikitina IM; Boiko VI; Smiian SA; Babar TV; Kalashnyk NV; Boiko AV; Іkonopystseva NА; Bolotna MA
    Wiad Lek; 2020; 73(5):868-872. PubMed ID: 32386360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curative effect of 1.88-mg and 3.75-mg gonadotrophin-releasing hormone agonist on stage III-IV endometriosis: Randomized controlled study.
    Tang H; Wu R; Li X; Zhou Y; Liu Z; Wang C; Chen Y; Zhang F
    J Obstet Gynaecol Res; 2017 Oct; 43(10):1550-1554. PubMed ID: 28707810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro fertilization and embryo transfer in patients with endometriosis: impact of a gonadotrophin releasing hormone agonist.
    Oehninger S; Brzyski RG; Muasher SJ; Acosta AA; Jones GS
    Hum Reprod; 1989 Jul; 4(5):541-4. PubMed ID: 2507576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell'Endometriosi.
    Parazzini F; Di Cintio E; Chatenoud L; Moroni S; Ardovino I; Struzziero E; Falsetti L; Bianchi A; Bracco G; Pellegrini A; Bertulessi C; Romanini C; Zupi E; Massobrio M; Guidetti D; Troiano L; Beretta P; Franchi M
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):11-4. PubMed ID: 10659911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment.
    Nirgianakis K; Bersinger NA; McKinnon B; Kostov P; Imboden S; Mueller MD
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):550-4. PubMed ID: 23993133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.
    Shifren JL; Tseng JF; Zaloudek CJ; Ryan IP; Meng YG; Ferrara N; Jaffe RB; Taylor RN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3112-8. PubMed ID: 8768883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis.
    Tamura H; Takasaki A; Nakamura Y; Numa F; Sugino N
    J Ovarian Res; 2014 Oct; 7():100. PubMed ID: 25331066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified ultralong protocol of gonadotrophin-releasing hormone agonist for ovulation induction with intrauterine insemination in patients with endometriosis.
    Kim CH; Cho YK; Mok JE
    Hum Reprod; 1996 Feb; 11(2):398-402. PubMed ID: 8671231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine ultrasonographic changes during endometriosis treatment: a comparison between levonorgestrel-releasing intrauterine devices and a gonadotropin-releasing hormone agonist.
    Manetta LA; de Paula Martins W; Rosa e Silva JC; de Sá Rosa e Silva AC; Nogueira AA; Ferriani RA
    Ultrasound Med Biol; 2008 Dec; 34(12):1914-8. PubMed ID: 18597921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
    McLaren J; Prentice A; Charnock-Jones DS; Millican SA; Müller KH; Sharkey AM; Smith SK
    J Clin Invest; 1996 Jul; 98(2):482-9. PubMed ID: 8755660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelvic endometriosis with peritoneal fluid reduces pregnancy rates in women undergoing intrauterine insemination.
    Wu HM; Tzeng CR; Chen CH; Chen PH
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):512-5. PubMed ID: 24411035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothetical roadmap towards endometriosis: prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections.
    García-Peñarrubia P; Ruiz-Alcaraz AJ; Martínez-Esparza M; Marín P; Machado-Linde F
    Hum Reprod Update; 2020 Feb; 26(2):214-246. PubMed ID: 32108227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometritis in Infertile Couples: The Role of Hysteroscopy and Bacterial Endotoxin.
    Viana GA; Cela V; Ruggiero M; Pluchino N; Genazzani AR; Tantini C
    JBRA Assist Reprod; 2015 Feb; 19(1):21-3. PubMed ID: 27205862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Killer inhibitory receptor CD158a overexpression among natural killer cells in women with endometriosis is undiminished by laparoscopic surgery and gonadotropin releasing hormone agonist treatment.
    Maeda N; Izumiya C; Kusum T; Masumoto T; Yamashita C; Yamamoto Y; Oguri H; Fukaya T
    Am J Reprod Immunol; 2004 May; 51(5):364-72. PubMed ID: 15212673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disrupted iron metabolism in peritoneal fluid may induce oxidative stress in the peritoneal cavity of women with endometriosis.
    Polak G; Barczyński B; Wertel I; Kwaśniewski W; Bednarek W; Derewianka-Polak M; Frąszczak K; Olajossy M; Kotarski J
    Ann Agric Environ Med; 2018 Dec; 25(4):587-592. PubMed ID: 30586986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.